MEDIROM Healthcare Technologies EBIT

As of the most recent data (December 2025), MRM shows a EBIT of $160M. That compares with $-2.3M in the prior-year period — up 7127.8% year over year. That is below the Consumer Discretionary sector average of $150B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRM's EBIT is now $160M (was $-2.3M) — a 7127.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MEDIROM Healthcare Technologies is outperforming or lagging.

The Consumer Discretionary sector average EBIT is about $150B. MEDIROM Healthcare Technologies is at $160M, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how MRM stacks up against individual peers as well.

Tracking MRM's ebit over time shows whether MEDIROM Healthcare Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $-2.3M in the prior-year period — up 7127.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has MEDIROM Healthcare Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $160M) with ownership activity and broader fundamentals.